Discover key insights from Amarin's Q3 2025 earnings: cost savings, global partnerships, VASCEPA growth, and path to positive cash flow.

National HealthCare Corporation remains a buy despite lease renewal tensions with National Health Investors. Click here to ...

Are you watching Harmony Biosciences Holdings and wondering whether now is the moment to make your move? Over the past week, the stock has leapt 13.3%, catching the eye of both longtime holders and ...

Meta Platforms has gained over 1,200% since 2012. The company is now investing heavily in artificial intelligence, bolstering ...